Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

Clinical trial NCT05552755 · RECRUITING

Trial details

NCT number: NCT05552755
Sponsor: Recursion Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Familial Adenomatous Polyposis

Start date: 2023-07-10
Primary completion: 2027-06-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.